(Q38826299)

6 September 2017

Inactivation of Cancer Mutations Utilizing CRISPR/Cas9 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

Maciej Paszkowski-Rogacz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

Frank Buchholz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

Debojyoti Chakraborty

5

object named as

Debojyoti Chakraborty

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

author name string

Christina Gebler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

Jovan Mircetic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

Aylin Camgoz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

Martin V Hamann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

Mirko Theis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

Christian Thiede

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

30 August 2016

1 reference

Journal of the National Cancer Institute

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

cites work

Cancer genome landscapes

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Mutational landscape and significance across 12 major cancer types

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Clinical interpretation and implications of whole-genome sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

DNA targeting specificity of RNA-guided Cas9 nucleases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Genome engineering using the CRISPR-Cas9 system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Nucleosomes impede Cas9 access to DNA in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Orthogonal Cas9 proteins for RNA-guided gene regulation and editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Engineered CRISPR-Cas9 nucleases with altered PAM specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

Oncolytic viruses: a new class of immunotherapy drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJW183

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJW183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6284257&resulttype=core&format=json

13 May 2020

1 reference